Comparative Outcomes and Molecular Response Predictors of IDH1/2-mutated Adult Acute Myeloid Leukemia (AML) Patients (Pts) after Frontline Treatment with Intensive Induction Chemotherapy (IC), Targeted Inhibitors, or Hypomethylating Agents (HMA) (Alliance)
- Citation:
- Blood vol 138 (Supplement 1) 226
- Meeting Instance:
- ASH 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171;
- Corr. Author:
- Authors:
- Uma Borate Prapti Patel Chetasi Talati Jessica Kohlschmidt Michael Ozga Yazan Madanat Luke Fletcher Ravi Patel Krzysztof Mrózek Deedra Nicolet Akriti Jain Virginia Volpe Fei Yang Richard Press Daniel Jones James S. Blachly Andrew J. Carroll Guido Marcucci Maria Baer William G. Blum Bayard L. Powell Jonathan E. Kolitz Richard M. Stone John C. Byrd Alice S. Mims Kendra Sweet Ann-Kathrin Eisfeld
- Networks:
- CA043, FL065, LAPS-AL002, LAPS-MA036, LAPS-OH007, LAPS-PA015, LAPS-TX011, MD015, NC002, NORTHWELL, OH008, OH070
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202, CALGB-8461, CALGB-9665
- Phases:
- N/A
- Keywords: